Practical Strategies for Advanced Practitioners Streamlining the Integration of Oncology Biosimilar Therapies Into Practice

In oncology practices across the United States, biosimilars—highly similar versions of licensed, innovator (reference) biological medicines—are currently emerging as more affordable therapeutic options. Only after a rigorous product development program, during which a proposed biosimilar is analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayden, Kelley D., Kelton, John M., Ryan, Joanne C., McBride, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214965/
https://www.ncbi.nlm.nih.gov/pubmed/35755898
http://dx.doi.org/10.6004/jadpro.2022.13.4.5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214965/
https://www.ncbi.nlm.nih.gov/pubmed/35755898
http://dx.doi.org/10.6004/jadpro.2022.13.4.5

Ejemplares similares